Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$458K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 6 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 7 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 11 most recent Form 4 transactions.
| Apr 16 | RARE | Ultragenyx Pharmaceutical… | AGRANT◆ | 59,952 | — | — | — | Open the original filing on SEC.gov |
| Apr 16 | RARE | Ultragenyx Pharmaceutical… | AGRANT | 34,674 | — | — | +45.4% | Open the original filing on SEC.gov |
| Mar 2 | RARE | Ultragenyx Pharmaceutical… | SSELL | 7,029 | $22.80 | $160.3K | -8.4% | Open the original filing on SEC.gov |
| Mar 1 | RARE | Ultragenyx Pharmaceutical… | AGRANT | 11,643 | — | — | +16.3% | Open the original filing on SEC.gov |
| Feb 2 | ABEO | Abeona Therapeutics INC. | SSELL | 16,284 | $5.09 | $82.9K | -20.4% | Open the original filing on SEC.gov |
| Jan 26 | ABEO | Abeona Therapeutics INC. | AGRANT | 37,313 | — | — | +87.9% | Open the original filing on SEC.gov |
| Aug 14, 2025 | ABEO | Abeona Therapeutics INC. | SSELL | 4,718 | $6.93 | $32.7K | -10.0% | Open the original filing on SEC.gov |
| May 5, 2025 | RARE | Ultragenyx Pharmaceutical… | SSELL | 520 | $39.24 | $20.4K | -0.7% | Open the original filing on SEC.gov |
| Apr 21, 2025 | RARE | Ultragenyx Pharmaceutical… | SSELL | 242 | $35.11 | $8.5K | -0.3% | Open the original filing on SEC.gov |